FDA Inspection 1087025 — Actimus BioSciences Private Ltd.
The FDA completed an inspection of Actimus BioSciences Private Ltd. on Feb 22, 2019 in Gajuwaka. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 22, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Gajuwaka (India)
Additional Details
Bioanalytical BA/BE